-
Author
Amaral, Rita 1 Ansotegui, Ignacio J 1 Anto, Josep M 1 Arnavielhe, Sylvie 1 Basagaña, Xavier 1 Bedbrook, Anna 1 Benveniste, Samuel 1 Bergmann, Karl C 1 Bewick, Michael 1 Bindslev-Jensen, Carsten 1 Blain, Hubert 1 Bonini, Matteo 1 Bosnic-Anticevich, Sinthia 1 Bourret, Rodolphe 1 Bousquet, Jean 1 Braido, Fulvio 1 Brussino, Luisa 1 Bédard, Annabelle 1 Canonica, G Walter 1 Cardona, Victoria 1
-
Workplace
ALL MED Medical Research Institute Wroclaw P... 1 ARADyAL Research Network Barcelona Spain 1 ASA Advanced Solutions Accelerator Jacou France 1 Agency of Health ASL Salerno Italy 1 Allergist Reims France 1 Allergy Center CUF Descobertas Hospital Lisb... 1 Allergy Department 2nd Pediatric Clinic Univ... 1 Allergy Division Chest Disease Department Un... 1 Allergy Section Department of Internal Medic... 1 Allergy Unit D Kalogeromitros 2nd Department... 1 Allergy and Clinical Immunology Unit Centro ... 1 Asthma Reference Center School of Medicine o... 1 Berlin Institute of Health Berlin Germany 1 CIBER Epidemiología y Salud Pública Barcelon... 1 CINTESIS Health Research Network Faculty of ... 1 CIRFF Department of Pharmacy University of N... 1 CRI Clinical Research International Ltd Hamb... 1 Center for Rhinology and Allergology Wiesbad... 1 Center of Allergy Immunology and Respiratory... 1 Center of Excellence in Asthma and Allergy M... 1
- Publication type
- Category
- Language
- Country
- Journal/source
- Grant support
- Most cited
Most cited article - PubMed ID 30746253
Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels
-
Bousquet, Jean
Author Authority ORCID Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany University Hospital Montpellier, Montpellier, France Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France
- Anto, Josep M
-
Sousa-Pinto, Bernardo
Author Sousa-Pinto, Bernardo MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal RISE - Health Research Network, MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal
- Czarlewski, Wienczyslawa
- Bedbrook, Anna
- Haahtela, Tari
- Klimek, Ludger
- Pfaar, Oliver
- Kuna, Piotr
- Kupczyk, Maciej
PubMed
36705508
PubMed Central
PMC9823305
DOI
10.1002/clt2.12215
Knihovny.cz E-resources
MASK-air® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Santé on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma.
Refine by MeSH
Share
Document title
The link will be redirected to the address of the production version after the testing phase.